9 Meters Biopharma, Inc.
NMTRQ
$0.00
$0.000.00%
| Weiss Ratings | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 61.47 | |||
| Price History | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -100.00% | |||
| 52-Week High % Change | -90.00% | |||
| 52-Week Low % Change | 900.00% | |||
| Price | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Apr 02, 2024 | |||
| 52-Week High Price (Date) | Jun 12, 2024 | |||
| Valuation | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 144.00 | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -3.52 | |||
| Earnings Per Share Growth | 4.97% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 13.59M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 919 275 1933 | |||
| Address | 4509 Creedmoor Road Raleigh, NC 27612 | |||
| Website | www.9meters.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -111.78% | |||
| Return on Equity | -- | |||
| Income Statement | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -43.43M | |||
| EBIT (TTM) | -43.44M | |||
| Net Income (TTM) | -46.28M | |||
| Net Income Avl. to Common (TTM) | -46.28M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -22.17% | |||
| EPS Diluted (TTM) | -3.52 | |||
| EPS Diluted Growth (Q YOY) | -15.94% | |||
| Balance Sheet | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.94M | |||
| Cash Per Share (Q) | $0.51 | |||
| Total Current Assets (Q) | 9.20M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -6.30M | |||
| Current Ratio (Q) | 0.590 | |||
| Book Value Per Share (Q) | -$0.44 | |||
| Total Assets (Q) | 9.31M | |||
| Total Current Liabilities (Q) | 15.58M | |||
| Total Debt (Q) | 5.17M | |||
| Total Liabilities (Q) | 15.61M | |||
| Total Common Equity (Q) | -6.30M | |||
| Cash Flow | NMTRQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 7.63M | |||
| Net Change in Cash (TTM) | -29.62M | |||
| Levered Free Cash Flow (TTM) | -21.02M | |||
| Cash from Operations (TTM) | -37.24M | |||
